| Authors: |
Hirschfield GM; The Autoimmune and Rare Liver Disease Programme, Division of Gastroenterology and Hepatology, University Health Network, Toronto General Hospital, Toronto, ON, Canada. Electronic address: gideon.hirschfield@uhn.ca., Bowlus CL; Division of Gastroenterology and Hepatology, University of California Davis School of Medicine, Sacramento, CA, USA., Jones DEJ; Institute of Cellular Medicine and NIHR Newcastle Biomedical Research Centre, Newcastle University, Newcastle upon Tyne, UK., Kremer AE; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Mayo MJ; University of Texas Southwestern Medical School, Dallas, TX, USA., Tanaka A; Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan., Andreone P; Medicina Interna Metabolica, Baggiovara Hospital, Azienda Ospedaliero-Universitaria di Modena and Università di Modena e Reggio Emilia, Modena, Italy., Jia J; Liver Research Centre, Beijing Friendship Hospital, Capital Medical University, Beijing, China., Jin Q; Department of Hepatology, The First Hospital of Jilin University, Changchun, China., Macías-Rodríguez RU; Division of Hepatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Cobitz AR; GSK, Collegeville, PA, USA., Currie BM; GSK, Collegeville, PA, USA., Gorey C; GSK, London, UK., Lazic I; GSK, London, UK., Podmore D; GSK, London, UK., Ribeiro A; GSK, Madrid, Spain., Shannon JB; GSK, Durham, NC, USA., Swift B; GSK, Durham, NC, USA., McLaughlin MM; GSK, Collegeville, PA, USA., Levy C; Division of Digestive Health and Liver Diseases and Schiff Center for Liver Diseases, University of Miami, Miami, FL, USA. |
